α,4-二甲基色胺

Α,4-二甲基色胺
臨床資料
給藥途徑	Oral
ATC碼	未分配;
法律規範狀態
法律規範	Uncontrolled (but may be covered under the Federal Analogue Act in the United States and under similar bills in other countries);
識別資訊
	IUPAC命名法 1-methyl-2-(4-methyl-1H-indol-3-yl)-ethylamine; ;
CAS號	3569-29-7
PubChem CID	28806639;
ChemSpider	25392939 ;
UNII	QY99ES7YWD;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID70708203 ;
化學資訊
化學式	C12H16N2
摩爾質量	188.27 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES CC(N)Cc2c1c([nH]c2)cccc1C;
	InChI InChI=1S/C12H16N2/c1-8-4-3-5-11-12(8)10(7-14-11)6-9(2)13/h3-5,7,9,14H,6,13H2,1-2H3 ; Key:KEOYEGHPRBDSKD-UHFFFAOYSA-N ;

Α,4-二甲基色胺（英語：4,α-dimethyltryptamine，縮寫4,α-DMT，或4-methyl-α-ethyltryptamine，縮寫4-Me-αMT），分子式C₁₂H₁₆N₂，是一種色胺衍生物，1960年代早期作為一種抗抑鬱藥開發出來，代號MP-809，但從未上市^[1]^[2]。

參考文獻

^ Azima H, Arthurs D, Silver A, Azima FJ. The effect of MP-809 in depressive states: a multi-blind study. The American Journal of Psychiatry. December 1962, 119 (6): 573–4. PMID 13965759. doi:10.1176/ajp.119.6.573.
^ Brodey JF, Steiner WG, Himwich HE. An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809). The Journal of Pharmacology and Experimental Therapeutics. April 1963, 140: 8–18. PMID 14015664.

外部連結

[pmid13965759-1] Azima H, Arthurs D, Silver A, Azima FJ. The effect of MP-809 in depressive states: a multi-blind study. The American Journal of Psychiatry. December 1962, 119 (6): 573–4. PMID 13965759. doi:10.1176/ajp.119.6.573.

[2] Brodey JF, Steiner WG, Himwich HE. An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809). The Journal of Pharmacology and Experimental Therapeutics. April 1963, 140: 8–18. PMID 14015664.

[1]

[2]